NFSG
CRVO icon

Newbridge Financial Services Group’s CervoMed CRVO Stock Holding History

Newbridge Financial Services Group’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8K Hold
3,000
– – ﹤0.01% 765
2025
Q4 		$23.7K Buy
+3,000
New +$24.1K ﹤0.01% 597

Other funds holding CRVO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Newbridge Financial Services Group's CRVO Position: Q1 2026 in Review

Newbridge Financial Services Group held its CervoMed (CRVO) position steady in Q1 2026 at 3,000 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Newbridge Financial Services Group first reported a position in CRVO in Q4 2025 and has held it in 2 quarters since. The position peaked at $23.7K in Q4 2025. 36 funds tracked by Wall St. Rank hold CRVO as of Q1 2026.

  • Newbridge Financial Services Group held 3,000 shares of CervoMed worth $11.8K as of Q1 2026.
  • Newbridge Financial Services Group left its CervoMed share count unchanged in Q1 2026.
  • CervoMed made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #765 holding.
  • Newbridge Financial Services Group first reported a position in CervoMed in Q4 2025 and has held it in 2 quarters since.
  • Newbridge Financial Services Group's CervoMed position peaked at $23.7K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.